Document is current
Any future updates will be listed below
-
Authors
Bruel, Timothée https://orcid.org/0000-0002-3952-4261
Hadjadj, Jérôme
Maes, Piet https://orcid.org/0000-0002-4571-5232
Planas, Delphine
Seve, Aymeric
Staropoli, Isabelle
Guivel-Benhassine, Florence
Porrot, Françoise https://orcid.org/0000-0001-8995-3614
Bolland, William-Henry
Nguyen, Yann https://orcid.org/0000-0002-0866-3824
Casadevall, Marion
Charre, Caroline
Péré, Hélène
Veyer, David
Prot, Matthieu
Baidaliuk, Artem
Cuypers, Lize
Planchais, Cyril
Mouquet, Hugo
Baele, Guy https://orcid.org/0000-0002-1915-7732
Mouthon, Luc
Hocqueloux, Laurent https://orcid.org/0000-0002-2264-4822
Simon-Loriere, Etienne https://orcid.org/0000-0001-8420-7743
André, Emmanuel
Terrier, Benjamin
Prazuck, Thierry
Schwartz, Olivier https://orcid.org/0000-0002-0729-1475
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-LABX-77, ANR-10-LABX-62-IBEID, PROTEO-SARS-CoV-2)
- License Information
-
More Information
Article History
Received: 6 March 2022
Accepted: 22 March 2022
First Online: 23 March 2022
Competing interests
: T.B., C.P., H.M. and O.S. have a pending patent application for an anti-RBD mAb not used in this study (PCT/FR2021/070522). All other authors declare no conflicts of interest.
Free to read: This content has been made available to all.
